The President’s Drug-Pricing Scam

Robert Reich / RobertReich.Org May 13, 2018 Donald Trump promised to rein in drug prices, but his plan does little but add another battering ram to his ongoing economic war against America’s allies. Dig deeper ( 4 Min. Read )

The Bayer-Monsanto Merger Is Bad News for the Planet

Ellen Brown / Truthdig Apr 3, 2018 The Trump administration should veto the chemical giants' pending merger to protect not just competitors but human and environmental health. Dig deeper ( 7 Min. Read )

Tackling Opioid Addiction in Indian Country

Chelsey Luger / Truthdig Feb 12, 2018 Pharmaceutical companies should be held accountable for their role in further damaging Native peoples’ well-being, but that’s only the beginning. Dig deeper ( 4 Min. Read )

Some Pay More to Buy Prescription Drugs With Insurance Than Without It

Charles Ornstein / ProPublica, and Katie Thomas / The New York Times Dec 11, 2017 As insurers ask consumers to pay a greater share of their drug costs, it may be cheaper to pay cash than use an insurance card. Dig deeper ( 7 Min. Read )

Take the Generic Drug—Unless Insurers Say No, Patients Told

By Charles Ornstein / ProPublica, and Katie Thomas / The New York Times Aug 7, 2017 Some pharmaceutical companies are cutting deals with insurers to favor brand-name products over cheaper versions. Dig deeper ( 8 Min. Read )

The Myth of Drug Expiration Dates

By Marshall Allen / ProPublica Jul 19, 2017 Hospitals and pharmacies are required to discard expired drugs, no matter how costly or vital they are. Meanwhile, the FDA has long known that many remain safe and potent for years. Dig deeper ( 11 Min. Read )

Sen. Dianne Feinstein Benefits From Health Care Lobbyists After Dismissing a Single-Payer System

Emma Niles / Truthdig May 2, 2017 The California Democrat attended a fundraising event held by a big-pharma lobbying firm a week after constituents booed her stance on single-payer health care. (Pictured, a protester at a Feinstein event in February.) Dig deeper ( 3 Min. Read )

Conflict-of-Interest Questions Dog Chief of Health and Human Services

By Robert Faturechi / ProPublica Apr 5, 2017 While in Congress, HHS Secretary Tom Price acquired up to $90,000 of pharmaceutical stock the same day he intervened on a rule that would hurt drug profits. Dig deeper ( 4 Min. Read )

Bernie Sanders Takes On Drug Pricing (Again), This Time With Help From ‘Big-Pharma Dems’

Staff / Truthdig Mar 1, 2017 Lawmakers call on President Trump to honor his campaign promises and back their bill when he addresses Congress Tuesday night. Dig deeper ( 2 Min. Read )

Big Pharma Enlists Leading Professors to Justify $1,000-a-Day Drugs

Staff / Truthdig Feb 26, 2017 As it readies for battle with President Trump over drug prices, the pharmaceutical industry is deploying economists and health care experts from top universities. Dig deeper ( 21 Min. Read )

Big Pharma-Backed Democrats Join GOP to Block Bernie Sanders’ Effort to End Drug Price Gouging

By Lauren McCauley / Common Dreams Jan 13, 2017 Sen. Cory Booker and others drew sharp rebuke from observers who pointed out that many who voted "no" receive substantial contributions from the pharmaceutical industry. Dig deeper ( 3 Min. Read )

John Oliver on How Opioid Addiction Is Creating a Massive Public Health Crisis (Video)

Natasha Hakimi Zapata / Truthdig Oct 24, 2016 The "Last Week Tonight" host delves into the painful truths behind the painkiller dependence that is ruining—and taking—many American lives. Dig deeper ( 1 Min. Read )